Cardinal Health acquires Cordis for $1.9 billion
Client(s) Cardinal Health, Inc.
Jones Day advised Cardinal Health, Inc. in its acquisition of Johnson & Johnson's Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $1.9 billion in cash.
In addition to M&A representation, Jones Day provided health care, intellectual property, employee benefits, antitrust, real estate, business and tort litigation, and global disputes advice regarding this transaction.